655 related articles for article (PubMed ID: 31702711)
1. Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
Midha N; Gillmann K; Chaudhary A; Mermoud A; Mansouri K
J Glaucoma; 2020 Jan; 29(1):11-14. PubMed ID: 31702711
[TBL] [Abstract][Full Text] [Related]
2. Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results.
Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
J Glaucoma; 2020 Mar; 29(3):155-160. PubMed ID: 32108690
[TBL] [Abstract][Full Text] [Related]
3. [XEN
Buffault J; Baudouin C; Labbé A
J Fr Ophtalmol; 2019 Apr; 42(4):391-403. PubMed ID: 30879831
[TBL] [Abstract][Full Text] [Related]
4. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B
Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702
[TBL] [Abstract][Full Text] [Related]
5. Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results.
Mansouri K; Guidotti J; Rao HL; Ouabas A; D'Alessandro E; Roy S; Mermoud A
J Glaucoma; 2018 Feb; 27(2):140-147. PubMed ID: 29271806
[TBL] [Abstract][Full Text] [Related]
6. Urgent Management of Secondary Glaucoma in Uveitis Using the Xen-45 Gel Stent.
Qureshi A; Jones NP; Au L
J Glaucoma; 2019 Dec; 28(12):1061-1066. PubMed ID: 31633616
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of postoperative management with 5-fluorouracil injections after XEN Gel Stent implantation.
Wałek E; Przeździecka-Dołyk J; Helemejko I; Misiuk-Hojło M
Int Ophthalmol; 2020 Jan; 40(1):235-246. PubMed ID: 31578662
[TBL] [Abstract][Full Text] [Related]
8. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study.
Lenzhofer M; Kersten-Gomez I; Sheybani A; Gulamhusein H; Strohmaier C; Hohensinn M; Burkhard Dick H; Hitzl W; Eisenkopf L; Sedarous F; Ahmed II; Reitsamer HA
Clin Exp Ophthalmol; 2019 Jul; 47(5):581-587. PubMed ID: 30578661
[TBL] [Abstract][Full Text] [Related]
9. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.
Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
Acta Ophthalmol; 2021 Jun; 99(4):e531-e539. PubMed ID: 32930515
[TBL] [Abstract][Full Text] [Related]
10. Two-Year Outcomes of XEN Gel Stent Surgery in Patients with Open-Angle Glaucoma.
Mansouri K; Bravetti GE; Gillmann K; Rao HL; Ch'ng TW; Mermoud A
Ophthalmol Glaucoma; 2019; 2(5):309-318. PubMed ID: 32672673
[TBL] [Abstract][Full Text] [Related]
11. One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients.
Ibáñez-Muñoz A; Soto-Biforcos VS; Chacón-González M; Rúa-Galisteo O; Arrieta-Los Santos A; Lizuain-Abadía ME; Del Río Mayor JL
Eur J Ophthalmol; 2019 May; 29(3):309-314. PubMed ID: 30145910
[TBL] [Abstract][Full Text] [Related]
12. XEN
Buffault J; Baudouin C; Labbé A
J Fr Ophtalmol; 2019 Feb; 42(2):e37-e46. PubMed ID: 30683533
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma Gel Implant Learning Curve in a Teaching Tertiary Hospital.
Marques RE; Ferreira NP; Sousa DC; Pinto J; Barata A; Sens P; Abegão Pinto L
J Glaucoma; 2019 Jan; 28(1):56-60. PubMed ID: 30312282
[TBL] [Abstract][Full Text] [Related]
14. Needle Revision With 5-fluorouracil for the Treatment of Ahmed Glaucoma Valve Filtering Blebs: 5-Fluoruracil Needling Revision can be a Useful and Safe Tool in the Management of Failing Ahmed Glaucoma Valve Filtering Blebs.
Quaranta L; Floriani I; Hollander L; Poli D; Katsanos A; Konstas AG
J Glaucoma; 2016 Apr; 25(4):e367-71. PubMed ID: 26766399
[TBL] [Abstract][Full Text] [Related]
15. Real-World Retrospective Consecutive Study of Ab Interno XEN 45 Gel Stent Implant with Mitomycin C in Black and Afro-Latino Patients with Glaucoma: 40% Required Secondary Glaucoma Surgery at 1 Year.
Laroche D; Nkrumah G; Ng C
Middle East Afr J Ophthalmol; 2019; 26(4):229-234. PubMed ID: 32153335
[TBL] [Abstract][Full Text] [Related]
16. 1-year outcomes of the Xen45 glaucoma implant.
Smith M; Charles R; Abdel-Hay A; Shah B; Byles D; Lim LA; Rossiter J; Kuo CH; Chapman P; Robertson S
Eye (Lond); 2019 May; 33(5):761-766. PubMed ID: 30552422
[TBL] [Abstract][Full Text] [Related]
17. Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation.
Lenzhofer M; Strohmaier C; Sperl P; Hohensinn M; Hitzl W; Steiner V; Moussa S; Motloch K; Baca B; Krall E; Reitsamer HA
Acta Ophthalmol; 2019 Dec; 97(8):e1105-e1111. PubMed ID: 31210015
[TBL] [Abstract][Full Text] [Related]
18. XEN
Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
[TBL] [Abstract][Full Text] [Related]
19. XEN 45 Gel Stent Implantation in Open Angle Glaucoma: 5-Year Results of a Prospective Study.
Torbey J; Paillard A; Rao HL; Gillman K; Bravetti GE; Mermoud A; Mansouri K
J Glaucoma; 2023 Nov; 32(11):909-917. PubMed ID: 37725786
[TBL] [Abstract][Full Text] [Related]
20. Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months.
Grover DS; Flynn WJ; Bashford KP; Lewis RA; Duh YJ; Nangia RS; Niksch B
Am J Ophthalmol; 2017 Nov; 183():25-36. PubMed ID: 28784554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
